COL1A1: A novel oncogenic gene and therapeutic target in malignancies

Xue Li(Department of Health), Fang Han(Weifang Medical University), Xiaodong Sun(Hubei University of Medicine), Bing Chen(Shanghai Medical College of Fudan University), Yongping Liu(Weifang Medical University), Chengxia Kan(Weifang Medical University), Na Qu(Yangzhou University), Ningning Hou(Weifang Medical University)
Pathology - Research and Practice
July 5, 2022
10.1016/j.prp.2022.154013
Cited by 112

Related Papers

Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis
|BMJ|2021|809
Mapping ICD-10 and ICD-10-CM Codes to Phecodes: Workflow Development and Initial Evaluation
|JMIR Medical Informatics|2019|558
Single-Cell RNA Sequencing Identifies Extracellular Matrix Gene Expression by Pancreatic Circulating Tumor Cells
|Cell Reports|2014|544
Global Disease Burden Estimates of Respiratory Syncytial Virus–Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis
|The Journal of Infectious Diseases|2019|522
circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer
|Molecular Therapy|2019|513